{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:02:43Z","timestamp":1791547363137,"version":"4.3.4"},"reference-count":33,"publisher":"Royal College of Psychiatrists","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["BJPsych open"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>Anorexia nervosa is characterised by the fear of gaining weight and a disrupted relationship with food but atypical if the body mass index is within normal limits. Semaglutide is a glucagon-like peptide-1 receptor agonist, indicated in patients with diabetes type 2 and obesity. An adolescent girl was diagnosed with atypical anorexia nervosa. She had a fear of gaining weight, she increased her exercise and decreased her caloric intake. The adolescent was admitted to the paediatric ward with bradycardia and pericardial effusion. During her hospital stay she admitted to having used semaglutide. Semaglutide was prescribed by her general practitioner because she was previously on the verge of being overweight with weight-related dysphoria. After 3 months she stopped using semaglutide, she kept losing weight. The adolescent girl went back to her normal life but after a panic attack caused by gaining 1 kg, she was admitted to an eating disorder ward. Semaglutide can affect mental health in patients who are prone to mental disorders. The importance of restrictively prescribing semaglutide for the right indication with caution and strict follow up is emphasised.<\/jats:p>","DOI":"10.1192\/bjo.2025.10909","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T01:06:24Z","timestamp":1764551184000},"update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":4,"title":["Semaglutide-associated worsening of atypical anorexia nervosa in an adolescent girl: case report"],"prefix":"10.1192","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3801-2177","authenticated-orcid":false,"given":"Lisa","family":"Liekens","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/008x57b05","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Antwerp"},{"name":"AZ Voorkempen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Ka\u00efret","sequence":"additional","affiliation":[{"name":"AZ Voorkempen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth F.","family":"Elst","sequence":"additional","affiliation":[{"name":"AZ Voorkempen"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"170","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"S2056472425109095_ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30013-X"},{"key":"S2056472425109095_ref27","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001820"},{"key":"S2056472425109095_ref9","first-page":"70","article-title":"Anorexia nervosa\/atypical anorexia nervosa","volume":"47","author":"Moskowitz","year":"2017","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"key":"S2056472425109095_ref17","doi-asserted-by":"publisher","DOI":"10.1002\/eat.22462"},{"key":"S2056472425109095_ref31","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1330936"},{"key":"S2056472425109095_ref24","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0000000000001379"},{"key":"S2056472425109095_ref14","doi-asserted-by":"publisher","DOI":"10.1002\/eat.22481"},{"key":"S2056472425109095_ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-024-01796-6"},{"key":"S2056472425109095_ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s40519-014-0138-z"},{"key":"S2056472425109095_ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bodyim.2024.101807"},{"key":"S2056472425109095_ref7","volume-title":"Gewichtstoestand en eetstoornissen: Eetstoornissen, Voedselconsumptiepeiling 2022\u20132023","year":"2024"},{"key":"S2056472425109095_ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.psc.2019.01.009"},{"key":"S2056472425109095_ref29","doi-asserted-by":"publisher","DOI":"10.3390\/ph16070994"},{"key":"S2056472425109095_ref13","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-4080"},{"key":"S2056472425109095_ref3","first-page":"46","article-title":"Initial evaluation, diagnosis, and treatment of anorexia nervosa and bulimia nervosa","volume":"91","author":"Harrington","year":"2015","journal-title":"Am Fam Physician"},{"key":"S2056472425109095_ref15","volume-title":"Anorexia Nervosa in Adults and Adolescents: Medical Complications and Their Management","author":"Mehler","year":"2024"},{"key":"S2056472425109095_ref23","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0000000000001365"},{"key":"S2056472425109095_ref26","doi-asserted-by":"publisher","DOI":"10.3109\/03014460903049074"},{"key":"S2056472425109095_ref28","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001206"},{"key":"S2056472425109095_ref12","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-2339"},{"key":"S2056472425109095_ref21","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15816"},{"key":"S2056472425109095_ref33","doi-asserted-by":"publisher","DOI":"10.1080\/15622975.2023.2179663"},{"key":"S2056472425109095_ref5","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000818"},{"key":"S2056472425109095_ref8","doi-asserted-by":"publisher","DOI":"10.1002\/eat.23856"},{"key":"S2056472425109095_ref11","doi-asserted-by":"publisher","DOI":"10.1111\/jcap.12394"},{"key":"S2056472425109095_ref25","volume-title":"European Medicines Agency Decision P\/0296\/2023 of 11 August 2023 on the Granting of a Product Specific Waiver for Semaglutide (Wegovy), (EMEA-001441-PIP08-23 in Accordance with Regulation (EC) No 1901\/2006 of the European Parliament and of the Council","year":"2023"},{"key":"S2056472425109095_ref30","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13111503"},{"key":"S2056472425109095_ref4","volume-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5","year":"2013"},{"key":"S2056472425109095_ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s40519-020-00867-x"},{"key":"S2056472425109095_ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2208601"},{"key":"S2056472425109095_ref2","doi-asserted-by":"publisher","DOI":"10.12968\/hmed.2020.0099"},{"key":"S2056472425109095_ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s40337-022-00720-9"},{"key":"S2056472425109095_ref22","doi-asserted-by":"publisher","DOI":"10.1002\/oby.23808"}],"container-title":["BJPsych Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S2056472425109095","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T01:19:20Z","timestamp":1766711960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S2056472425109095\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["S2056472425109095"],"URL":"https:\/\/doi.org\/10.1192\/bjo.2025.10909","relation":{},"ISSN":["2056-4724"],"issn-type":[{"value":"2056-4724","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"\u00a9 The Author(s), 2025. Published by Cambridge University Press on behalf of Royal College of Psychiatrists","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial licence (https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original article is properly cited. The written permission of Cambridge University Press must be obtained prior to any commercial use.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"e2"}}